TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeutics, Inc. Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60…
New Review Finds Creatine Shows Promise for Depression With Major Caveats
Credit: Pexels Creatine is among the most studied supplements in sports, with evidence that it can boost strength,…
3 Companies Redefining Healthcare Innovation
This article was originally published on ETFTrends.com. The Healthcare Technology and Innovation index (HTEC) was launched back in…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
The Drug That Bought My Father More Time Didn’t Happen by Accident
I still remember the day my father and I sat in his oncologist’s office and first heard the…
Targeting Delivery to the Lungs: Inhaled Vitamin D Could Be New Strategy
Newswise — People with chronic lung diseases like chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis tend…
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
The World Has Learned From the Last Ebola Outbreak, but Gaps Remain
The response to the Ebola outbreak in East Africa, as troubled as it has been, offers signs that…
New York Valves 2026 To Unveil Late-Breaking Research in Structural Heart Disease
Newswise — NEW YORK – June 2, 2026 – The Cardiovascular Research Foundation® (CRF®) announced the highly anticipated…
Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell Therapies
Newswise — Scientists at Johns Hopkins Medicine say they used a form of magnetic imaging to track cell…
The Supplement That Science Says Could Make the World Less Angry
If you found out a supplement existed that could lower aggression, you would probably think it was something…